IP finance

"Where money issues meet IP rights". This weblog looks at financial issues for intellectual property rights: securitisation and collateral, IP valuation for acquisition and balance sheet purposes, tax and R&D breaks, film and product finance, calculating quantum of damages--anything that happens where IP meets money.

Showing posts with label access. Show all posts
Showing posts with label access. Show all posts
Tuesday, 17 March 2020

The Coronavirus Pandemic -- An Opportunity for the BioPharmaceutical Industry?

›
The Santa Cruz Sentinel (Wow!) has an excellent news article about a Gilead Sciences drug used (in combination with other treatments) to...
›
Home
View web version
Powered by Blogger.